GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

Decision Diagnostics DECN · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2020

Revenue

$2.0m

FY2014FY2020

Net income

−$29.7m

FY2014FY2020

Free cash flow

−$1.4m

FY2014FY2020

Shareholders' equity

$483,594

FY2014FY2020

Income statement

Fiscal years

FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Revenue$2.0m$2.4m$2.2m$1.9m$1.1m$514,994$426,525
Operating income−$2.1m−$1.3m−$1.9m−$2.5m−$3.0m−$2.5m−$1.3m
Net income−$29.7m−$3.1m−$2.2m−$3.0m−$3.2m−$2.8m−$1.8m
Diluted earnings per share-0.08-0.02-0.10-0.13-0.14-0.12-0.08

Balance sheet

At each fiscal year end

FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Total assets$5.7m$5.3m$4.2m$5.1m$6.2m$3.4m$4.1m
Total liabilities$5.2m$5.2m$3.1m$3.5m$3.9m$2.7m$4.1m
Debt———$2.0m$2.3m$1.7m$3.2m
Shareholders' equity$483,594$87,584$1.1m$1.6m$2.4m$623,437$63,380
Shares outstanding356m160m22m22m22m22m22m

Cash flow

Fiscal years

FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Cash from operations−$1.4m−$1.1m−$1.3m−$1.6m−$2.9m−$1.2m−$1.5m
Capital spending—−$116,375−$75,000−$64,890−$476,430−$260,995−$260,995
Free cash flow−$1.4m−$1.2m−$1.4m−$1.6m−$3.4m−$1.5m−$1.7m

Latest quarters

By quarter end

Sept 2021Jun 2021Mar 2021Dec 2020Sept 2020Jun 2020Mar 2020Sept 2019
Revenue$518,511$552,385$537,799$521,805$520,698$362,864$573,793$528,458
Operating income−$490,722−$237,369−$454,016−$750,434−$346,821−$397,002−$607,175−$285,923
Net income−$554,922−$301,569−$972,232−$6.9m−$4.7m−$17.2m−$768,462−$315,793
Diluted earnings per share-0.77-0.00-0.00-0.02-0.02-0.09-0.00-0.00
Total assets$5.3m$5.3m$5.5m$5.7m$6.0m$5.8m$6.3m$5.1m
Shareholders' equity−$52,130$40,205$334,574$483,594$255,266$468,222$23,174$2.2m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue1.7%30.9%-20.2%
Operating income-5.2%-3.2%—
Net income114.9%60.7%51.3%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-77.9%-91.0%-130.8%-42.1%
Net margin-752.6%-448.8%-436.2%-120.9%

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return0%0%0%750%171513%462%21%-77%-32%9%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 11-for-10 split · 28 Dec 2011
  • 14-to-1 reverse split · 1 Dec 2011

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.